• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

‘All we need is your attention’: People affected by Chagas disease call for increased action and awareness

Home > News

‘All we need is your attention’: People affected by Chagas disease call for increased action and awareness

Family in a rural setting in Colombia
14 Apr 2021
  • English
    • English
    • Español
    • Português
  • On World Chagas Day, people affected by Chagas disease ask the international community for comprehensive care for this neglected disease
  • Estimates indicate that Chagas affects more than 6 million people and causes 7,000 deaths per year

The International Federation of Associations of People Affected by Chagas Disease (FINDECHAGAS) called for more comprehensive action and increased awareness to end the silent Chagas pandemic, as it marks this year the second World Chagas Disease Day, approved by the World Health Organization (WHO) in 2019. FINDECHAGAS released the following statement:

‘Faced with the difficulties imposed by the COVID-19 pandemic, people affected by Chagas, as well as other neglected diseases, have been perceived to be more vulnerable, both because of our state of health and exposure to the new pandemic. In addition, health care programmes have reduced their ability to serve us due to efforts made in response to the pandemic.

‘Despite the COVID-19 pandemic, we must remember that people affected by Chagas suffer from one of the most neglected diseases on Earth. This new World Chagas Day is an important opportunity to draw attention to the disease and, above all, to remember that the care we need must be comprehensive.

‘The complexity of this problem requires different approaches, in addition to integrating Chagas prevention, attention, control, and surveillance into the regular activities of the health systems of our countries.

‘For this reason, we consider it very important that Chagas is part of maternal and child health control activities, but also to increase the training and awareness of professionals working in the health-care facilities closest to the rural and urban communities most affected by the disease in its diverse forms, both in endemic and non-endemic countries.

‘Chagas disease can cause very serious complications if it is not diagnosed and treated early. It can impact the ability of affected people to lead a healthy professional, social, and family life, and is also a cause of stigmatization. For all these reasons, advances in the care of people with Chagas disease will not be achieved through a single action or only the biomedical component, but by integrating all the necessary actions (intersectoral and interdisciplinary) so that we may no longer be underserved.

‘Every day, those affected by Chagas experience the difficulties that fighting this disease brings. So, count on us. We believe that the tools of control, diagnosis, and treatment can improve our quality of life and facilitate our struggle, as long as they are adapted to the contexts in which we live. That is why the coffee brown of the Earth and the green of hope are the colors that we choose to represent ourselves in the world.

‘If we are to achieve the goals of eliminating the disease as a public health problem by 2030, as approved by WHO member countries, all we need is your attention.’

About FINDECHAGAS

FINDECHAGAS is formed by associations from various parts of the world:

  • Argentina: (3) ENTRE RÍOS UNIDOS FRENTE AL CHAGAS/ CHAGAS DISEASE ALIANCE/ ASOCIACIÓN DE BAHÍA BLANCA ARG.
  • Bolivia: Cochabamba e Aiquile (4) CORAZONES UNIDOS POR EL CHAGAS/ Santa Cruz-ASSAMUCH/ASOCIACIÓN DE CHUQUISACA
  • Brazil: (4) ACHAGRASP, ASSOCIAÇÃO RIO CHAGAS, APDCIM, ACCAMP
  • Colombia: (1) ASOCHAGAS.
  • Spain: (3) BARCELONA-ASAPECHA, MURCIA-ASAPECHAMUR, VALENCIA-ACHACOVA
  • France: (1) ASAFRANC
  • USA: Virginia (1) LASOCHA.
  • Italy: Bergamo (1) AILMAC.
  • Mexico: Xalapa. Ver. (1) AMEPACH.
  • Switzerland: Geneva (1) ASWISSCHAGAS

https://findechagas.org/

Photo credit: Ana Ferreira-DNDi

Chagas disease

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License